Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Nicholas Andrikopoulos, Yuhuan Li, Luca Cecchetto, Aparna Nandakumar, Tatiana Da Ros, Thomas P. Davis, Kelly Velonia, Pu Chun Ke

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)


Amyloid diseases are global epidemics with no cure currently available. In the past decade, the use of engineered nanomaterials as inhibitors or probes against the pathogenic aggregation of amyloid peptides and proteins has emerged as a new frontier in nanomedicine. In this Minireview, we summarize for the first time the pivotal role of chemical synthesis in enabling the development of this multidisciplinary field.

Original languageEnglish
Pages (from-to)14422-14440
Number of pages19
Issue number27
Publication statusPublished - 16 Jul 2020

Cite this